Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cartei

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Cancer Investigation|January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group studyH Bleiberg, B Vanderlinden, M Buyse, et al.
Chirurgia Italiana|October 1, 1986
[Cyclophosphamide, adriamycin and platinum (CAP) in the preoperative neoadjuvant phase and the therapy phase]G Cartei, P Marsilio, G Morandini, et al.
Bone Marrow Transplantation|May 7, 2003
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapyF Patriarca, C Sacco, A Sperotto, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2000
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancerM O Nicoletto, R Padrini, F Galeotti, et al.
Il Giornale Di Chirurgia|March 1, 1993
[The use of totally implantable systems (TIS) for long-term endovenous therapy]M G Comandella, M Rossi, C Finco, et al.
European Journal of Gynaecological Oncology|January 1, 1981
A planned prospective study of combined treatment in stage III epithelial ovarian cancerM Fiorentino, A Onnis, V Fosser, et al.
Tumori|October 31, 1991
Evaluation of the circulating glycoprotein CA549 in mammary cancer and other malignanciesL Clocchiatti, F De Biasi, G Cartei, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patientsG Cartei, G Sava, G Salerno, et al.
Tumori|September 1, 1977
Tamoxifen in disseminated breast cancerE Ferrazzi, G Cartei, P De Besi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 24, 2007
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancerM O Nicoletto, S Tumolo, R Sorio, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Cancer Investigation|January 1, 1990
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group studyH Bleiberg, B Vanderlinden, M Buyse, et al.
Chirurgia Italiana|October 1, 1986
[Cyclophosphamide, adriamycin and platinum (CAP) in the preoperative neoadjuvant phase and the therapy phase]G Cartei, P Marsilio, G Morandini, et al.
Bone Marrow Transplantation|May 7, 2003
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapyF Patriarca, C Sacco, A Sperotto, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2000
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancerM O Nicoletto, R Padrini, F Galeotti, et al.
Il Giornale Di Chirurgia|March 1, 1993
[The use of totally implantable systems (TIS) for long-term endovenous therapy]M G Comandella, M Rossi, C Finco, et al.
European Journal of Gynaecological Oncology|January 1, 1981
A planned prospective study of combined treatment in stage III epithelial ovarian cancerM Fiorentino, A Onnis, V Fosser, et al.
Tumori|October 31, 1991
Evaluation of the circulating glycoprotein CA549 in mammary cancer and other malignanciesL Clocchiatti, F De Biasi, G Cartei, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patientsG Cartei, G Sava, G Salerno, et al.
Tumori|September 1, 1977
Tamoxifen in disseminated breast cancerE Ferrazzi, G Cartei, P De Besi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 24, 2007
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancerM O Nicoletto, S Tumolo, R Sorio, et al.
Pageof 10